Drug-coated balloon angioplasty with provisional stenting versus primary stenting for the treatment of de novo coronary artery lesions: REC-CAGEFREE I trial rationale and design
Chao Gao(Xijing Hospital), Ling Tao(Xijing Hospital), Jianzheng Liu(Xijing Hospital), Duolao Wang(Guangdong Medical College), Xing Qin(First Affiliated Hospital of Xi'an Jiaotong University), Yunlong Xia(University of Washington), Ruining Zhang(Nanjing Agricultural University), Patrick W. Serruys(Erasmus MC), Jielai Xia(Air Force Medical University), Bin Zhu(National Institutes of Health), Xingqiang He(Qingdao University), Tingting Zhang(Brown University), Ping Wang(Army Medical University), Yunpeng Liu(Shenyang Institute of Automation), Zhiwei Jiang(Statistical Research (United States)), Yoshinobu Onuma(Ollscoil na Gaillimhe – University of Galway)
Cited by 11
Related Papers
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
|New England Journal of Medicine|2010|7.2k
Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
|New England Journal of Medicine|2011|6.4k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
|New England Journal of Medicine|2002|4k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k